DYNEX CAPITAL INC
Business
Dynex Capital, Inc. is an internally managed mortgage real estate investment trust that invests primarily in mortgage-backed securities and manages a leveraged portfolio focused on capital preservation. It offers investment exposure to agency residential and commercial mortgage-backed securities, to‑be‑announced contracts, interest-only CMBS securities, derivatives for hedging, and financing through repurchase agreements. The company's operations are organized around investment, financing, hedging and risk-management activities governed by an Investment Policy and conducted within REIT and 1940 Act exemption constraints. Dynex distributes investments via broker‑dealers, repurchase‑agreement lenders and institutional U.S. markets.
Summary from filing dated 2025-02-28
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Interest income | 534 | 320 | 208 | 87 | 60 | |
| Interest expense | −419 | −314 | −215 | 44 | — | |
| Net interest income (expense) | 114 | 6 | −8 | 43 | 54 | |
| Unrealized gain (loss) on investments, net | 371 | −142 | 143 | −213 | −15 | |
| (Loss) gain on derivative instruments, net | −113 | 288 | −33 | 436 | 81 | |
| Total other gains, net | 258 | 145 | 35 | 134 | 73 | |
| Compensation and benefits | −35 | −21 | −17 | −17 | −13 | |
| Other general and administrative | −16 | −14 | −14 | −16 | −11 | |
| Other operating expenses | −2 | −2 | −2 | −1 | −1 | |
| Total operating expenses | −53 | −36 | −33 | −34 | −25 | |
| Net income (loss) | 319 | 114 | −6 | 143 | 102 | |
| Preferred stock dividends | — | −8 | −8 | −8 | −8 | |
| Net income (loss) to common shareholders | 309 | 106 | −14 | 135 | 91 | |
| Unrealized gain (loss) on available-for-sale investments, net | 45 | −14 | 23 | −202 | −67 | |
| Comprehensive income to common shareholders | 354 | 92 | 9 | −53 | 17 | |
| Weighted average common shares-basic (in shares) | 124 | 71 | 55 | 42 | 33 | |
| Weighted average common shares-diluted (in shares) | 125 | 71 | 55 | 43 | 33 | |
| Net income (loss) per common share-basic (in dollars per share) | 2.49 | 1.5 | −0.25 | 3.19 | 2.79 | |
| Net income (loss) per common share-diluted (in dollars per share) | 2.47 | 1.49 | −0.25 | 3.17 | 2.78 | |
| Realized loss on sales of investments, net | 0 | −2 | −75 | −89 | 7 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 531 | 377 | 120 | 332 | 366 | |
| Cash collateral posted to counterparties | 399 | 244 | 118 | 118 | 55 | |
| Mortgage-backed securities (including pledged assets of $14,593,470 and $6,893,629, respectively), at fair value | 16,307 | 7,512 | 6,039 | 3,113 | 3,182 | |
| Due from counterparties | 17 | 10 | 1 | 10 | 3 | |
| Derivative assets | 10 | 133,000 | 54 | 7 | 8 | |
| Accrued interest receivable | 68 | 33 | 29 | 15 | 14 | |
| Other assets | 9 | 8 | 9 | 10 | 7 | |
| Total assets | 17,342 | 8,185 | 6,370 | 3,605 | 3,640 | |
| Repurchase agreements | 13,904 | 6,563 | 5,381 | 2,644 | 2,850 | |
| Due to counterparties | 812 | 342 | 95,000 | 4 | 2 | |
| Derivative liabilities | 5 | 23 | 0 | 23 | 0 | |
| Cash collateral posted by counterparties | 8 | 0 | 46 | 435,000 | 2 | |
| Accrued interest payable | 95 | 45 | 53 | 17 | 1 | |
| Dividends payable | 37 | 17 | 10 | 9 | 7 | |
| Other liabilities | 19 | 11 | 8 | 7 | 6 | |
| Total liabilities | 14,880 | 7,000 | 5,499 | 2,704 | 2,868 | |
| Preferred stock, par value $0.01 per share; 50,000,000 shares authorized; 4,460,000 and 4,460,000 shares issued and outstanding, respectively ($111,500 and $111,500 aggregate liquidation preference, respectively) | 108 | 108 | 108 | 108 | 108 | |
| Common stock, par value $0.01 per share, 360,000,000 shares authorized; 174,814,912 and 84,491,800 shares issued and outstanding, respectively | 2 | 845,000 | 570,000 | 536,000 | 367,000 | |
| Additional paid-in capital | 2,922 | 1,742 | 1,404 | 1,358 | 1,108 | |
| Accumulated other comprehensive loss | −127 | −172 | −159 | −181 | 7 | |
| Accumulated deficit | −442 | −494 | −484 | −383 | −451 | |
| Total shareholders equity | 2,462 | 1,185 | 871 | 901 | 771 | |
| Total liabilities and shareholders equity | 17,342 | 8,185 | 6,370 | 3,605 | 3,640 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Realized loss on sales of investments, net | 0 | 2 | 75 | 89 | −7 | |
| Loss (gain) on derivative instruments, net | 113 | −288 | 33 | −436 | −81 | |
| Amortization of investment premiums, net | 26 | 48 | 75 | 98 | 118 | |
| Other amortization and depreciation | 2 | 2 | 2 | 2 | 2 | |
| Share-based compensation expense | 13 | 7 | 5 | 4 | 3 | |
| Increase in accrued interest receivable | −35 | −3 | −13 | −1 | 204,000 | |
| Increase (decrease) in accrued interest payable | 51 | −9 | 37 | 15 | −45,000 | |
| Change in other assets and liabilities, net | 3 | 234,000 | −2 | −2 | −5 | |
| Net cash provided by operating activities | 121 | 14 | 62 | 126 | 147 | |
| Purchases of investments | −8,882 | −1,872 | −3,578 | −1,553 | −1,542 | |
| Principal payments received on trading securities | 833 | 440 | 233 | 124 | 37 | |
| Principal payments received on available-for-sale investments | 120 | 75 | 86 | 226 | 394 | |
| Proceeds from sales of trading securities | 0 | 14 | 348 | 589 | 0 | |
| Principal payments received on mortgage loans held for investment | 549,000 | 762,000 | 889,000 | 2 | 2 | |
| Net (payments) receipts on derivative instruments | −153 | 363 | −96 | 454 | 86 | |
| Increase (decrease) in cash collateral posted by counterparties | 8 | −46 | 46 | −1 | −6 | |
| Net cash used in investing activities | −8,074 | −1,026 | −2,960 | −65 | −555 | |
| Borrowings under repurchase agreements | 143,888 | 66,437 | 23,502 | — | — | |
| Repayments of repurchase agreement borrowings | −136,547 | −65,255 | −20,766 | — | — | |
| Proceeds from issuance of common stock | 1,169 | 332 | 43 | 247 | 237 | |
| Cash paid for stock issuance costs | −157,000 | −231,000 | 0 | 0 | −329,000 | |
| Payments related to tax withholding for share-based compensation | −2 | −949,000 | −445,000 | −1 | −853,000 | |
| Dividends paid | −247 | −118 | −93 | −72 | −59 | |
| Net cash provided by financing activities | 8,262 | 1,395 | 2,686 | −32 | 520 | |
| Net increase (decrease) in cash, including cash posted to counterparties | 309 | 384 | −212 | 29 | 112 | |
| Cash paid for interest on repurchase agreements | 369 | 322 | 179 | 29 | 6 | |
| Noncash or Part Noncash Acquisition, Investments Acquired | 809 | 335 | 0 | — | — |